From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Intensive Insulin Therapy for Patients with Severe Sepsis? Not So Fast

Severe hypoglycemia and serious adverse events were more common in the intensive therapy group.

Intensive insulin therapy — designed to normalize blood glucose levels — is advocated increasingly for hyperglycemic patients in intensive care units. Nevertheless, convincing evidence of benefit comes mainly from only one trial conducted primarily in critically ill patients who had just undergone cardiac surgery (Journal Watch Nov 16 2001). In this new study, German researchers randomized about 500 ICU patients with severe sepsis to intensive insulin therapy (initiated when glucose levels exceeded 110 mg/dL; target, 80–110 mg/dL) or to conventional insulin therapy (initiated when glucose levels exceeded 200 mg/dL; target, 180–200 mg/dL). To compare colloid and crystalloid therapy, patients were also randomized to receive hydroxyethyl starch (HES) or Ringer’s lactate for fluid resuscitation.

The trial was halted early for safety reasons. At 1 month, morbidity and mortality were virtually identical in the intensive and conventional insulin groups, but severe hypoglycemia and serious adverse events were significantly more common in the intensive insulin group. In the fluid resuscitation portion of the trial, morbidity and mortality were similar in the HES and Ringer’s lactate groups, but renal failure was more common with HES.

Comment: In patients with severe sepsis, intensive insulin therapy was not beneficial and in fact was responsible for adverse events. These findings, coupled with the ambiguous results from a recent trial of intensive insulin therapy in medical ICU patients generally (Journal Watch Feb 10 2006), indicate that proponents of intensive insulin therapy to achieve euglycemia in the medical ICU are still on shaky ground.

Allan S. Brett, MD

Published in Journal Watch General Medicine January 24, 2008

Citation(s):

Brunkhorst FM et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008 Jan 10; 358:125.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.